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Objectives: To identify the effects of exogenous Angiotension II (AngII) on the
Hyperpolarization-Activated Cyclic Nucleotide-Gated Channel (HCN) current and its
mechanisms in Neonatal Rat Ventricle Cardiomyocytes (NRVM).
Methods: NRVM from 1- to 3-day-old Wister rats were prepared by collagenase
digestion, and incubated in 37C, 95% CO2 for patch-clamp recording. HCN channel
protein expression was detected by western-blotting analysis.
Results: Our data shown that exposure (-20 min) of NRVM to AngII (100 mmol/
L) markedly increased If density (4.70.6 pA/pF vs. 11.71.1 pA/pF) along
increased conductance (Gmax: 48.75.6 pS/pF vs. 192.664.1 pS/pF), a shift in
activation voltage (V1/2) to positive potentials (-81.21.6 mV vs. -64.72.0 mV)
and increase rate of activation (tact) (523.424.7 ms vs. 337.524.9 ms). More-
over, stimulation by AngII was largely inhibited by the non-speciﬁc tyrosine
kinase blocker genistein (1mmol/L) or the c-Src-speciﬁc inhibitor PP2 (10 mmol/L).
Augmented tyrosine phosphorylation of HCN2 channels with AngII treatment by
determined by AngII Western blot using the phosphotyrosine speciﬁc antibody
4G10. Furthermore, the augmented If current was inhibited by pre-treatment with
Trx receptor inhibitor (Auranoﬁn 10nmol/L; 13-cis-retinoic acid 1 mmol/L). On the
other hand, If current of NRVMs was also increased by treated with non-speciﬁc
PTP inhibitors, phenylarsine oxide (PAO 1 mmol/L) or Na-orthovanadate (Na3VO4
10 mmol/L).
Conclusions: These data suggest that the c-Src family of tyrosine kinase mediate the
augmentation of If density by oxidant agent AngII via a redox mechanism involving
the Trx system. The studies will provide new insights into the re ation of oxidative cell
damage and ion channel remodeling.
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Angiotensin-(1-7) inhibits vascular remodeling in rat jugular vein grafts via
increased Akt/eNOS activity
Xun Nan, Wu Jingguo
First Afﬁliated Hospital, Sun Yat-sen University
Objectives: This study evaluated the effects of Angiotensin-(1-7) [Ang-(1-7)] on
vascular remodeling in autologous jugular vein grafts in a rat model.
Methods: Rats underwent autologous jugular vein graft transplantation (Ang-[1-7]
and control groups), or a sham operation (sham group). Three days after operation,
minipumps were installed for continuous infusion of Ang-(1-7) (25 mg/kg/h) or
normal saline (control and sham groups) through the jugular vein. There was no
signiﬁcant difference between groups in weight, blood pressure and heart rate after
4 weeks.
Results: Continuous Ang-(1-7) infusion caused attenuation of venous-graft hyper-
plasia, vascular remodeling and increasing Akt/eNOS activity compared to the control
group. Tissue angiotensin II expression was increased in the Ang-(1-7) and control
groups compared to the sham group. Our results suggest that exogenous Ang-(1-7)
interferes with the vascular remodeling of autologous jugular vein grafts and signif-
icantly inhibits vein-graft intimal hyperplasia via increasing of vascular tissue Akt/
eNOS activation.
Conclusions: Exogenous Ang-(1-7) could improve the outcome of vein grafting via
attenuation of vascular remodeling.
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Morin, a ﬂavonoid, on lipid peroxidation and antioxidant status in experimental
myocardial ischemic rats
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Objectives: Myocardial infarction affects a large population in the world. Lipid
peroxide metabolism plays an important role in the pathology of myocardial
infarction. The present study was designed to investigate the antioxidant potential
of morin, a ﬂavonoid in isoproterenol (ISO) -induced myocardial infarction (MI), in
rats.
Methods:Male albino Wistar rats were pre-treated with morin (40 mg/kg), daily for a
period of 30 days. After the treatment period, ISO (85 mg/kg), was subcutaneously
injected in rats at an interval of 24 h for 2 days.
Results: ISO-administered rats showed elevated levels of thiobarbituric acid reactive
substances (TBARS), and lipid hydro-peroxide (LOOH), in plasma and heart. Pre-
treatment with morin, the above changes were signiﬁcantly reduced to near normal
level. ISO-administered rats showed decrease in the activities of superoxide dismutase
(SOD), catalase (CAT), glutathione peroxidase (GPx) and glutathione-S-transferase
(GST) in heart. In addition, decrease the levels non enzymatic antioxidants such as
reduced glutathione (GSH), vitamin C and vitamin E in plasma and heart while
ceruloplasmin in plasma.
Conclusions: Pretreatment with morin, reversed these above biochemical changes
towards normalcy. These ﬁndings revealed that, the morin possess antioxidant activity
in experimentally induced cardiac toxicity.C56 JACC Vol 64/16/Suppl C j OctobGW25-e3074
94 ATTG Insertion/Deletion Polymorphism of the NFKB1 Gene Is Associated
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Objectives: The nuclear factor kappa-light-chain-enhancer of activated B cells
(NF-kB) signaling pathway plays a key role in the regulatory network of inﬂamma-
tion. The deletion variant allele of the NFKB1 -94 insertion/deletion (ins/del) ATTG
promoter polymorphism leads to lower transcription levels of the p50 subunit, and the
variant allele has been associated with several inﬂammatory diseases as well as cor-
onary artery disease (CAD) with inﬂammation as an important part of the patho-
genesis. The aim of the present study was to assess the association between the human
NFKB1 gene polymorphism and CAD in a Han and Uygur population of China.
Methods: We used the following two independent case-control studies: a Han pop-
ulation (633 CAD patients and 616 control subjects) and a Uygur population (437
CAD patients and 356 control subjects). All participants were genotyped for the same
one single nucleotide polymorphism (SNP) (rs28362491) of the NFKB1 gene, i.e.
del/del (DD), ins/del (ID) and ins/ins (II) by real-time PCR.
Results: The distribution of the SNP (rs28362491) genotypes was signiﬁcantly
different between CAD and control participants in women of the Han (P¼0.029) and
the Uygur (P¼0.032) populations, but not in men. Further, DD carriers of the SNP in
the NFKB1 gene were more frequent in female CAD patients than in controls in both
the Han (23.2% versus 13.5%, P¼0.009) and the Uygur (19.8% versus 8.3%,
P¼0.012) population. The signiﬁcant difference between DD and ID+II genotypes
was retained after adjustment for covariates (for Han, OR: 1.805, P¼0.029 and for
Uygur, OR: 3.192, P¼0.011).
Conclusions: The DD genotype of the SNP (rs28362491) in the NFKB1 gene may be
a genetic marker of CAD in Han and Uygur women in China.
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Objectives: Revascularization is an essential machinery to compensate cardiac perfu-
sion and therefore to preserve cardiac function in chronic ischemic heart. Recently
aldehyde dehydrogenase 2 (ALDH2) has been reported to have protection role for
ischemic cardiomyocyte. Nearly half of Asian and 8% of world populations carry a
mutant allele of ALDH2. Therefore, this study was designed to determine whether
ALDH2 regulates angiogenesis under chronic ischemia condition and the underlying
mechanism.We also test the clinical impact ofALDH2mutant allele on the development
of the coronary collateral circulation in coronary chronic total occlusions.
Methods: Mice limb ischemia was performed by femoral artery ligation in ALDH2-
knockout (KO) and C57BL/6 wild type mice (KO). One day, 1 and 3 weeks after
surgery, blood perfusion recovery, small artery density, gastrocnemius muscle atrophy
were evaluated. ALDH2, 4-HNE, HIF-1a and VEGF were tested by immunoblot. A
total of 200 CTO patients were extracted among angiography cases performed in
Zhongshan hospital by the inclusion criteria of (1) at least one of the right coronary
artery, left main coronary artery, left anterior descending artery or left circumﬂex
artery ﬂow 0, and (2) duration of ischemic manifestations of more than 3 months; by
the exclusion criteria of (1) undergoing acute myocardial infarction, (2) previous
percutaneous coronary intervention or coronary artery bypass grafting, or (3)
congenital heart diseases or valvular heart diseases. According to the coronary angi-
ography image, CCVs were graded by Rentrop classiﬁcation, grade 0 or I were taken
as poor CCVs and gradeII or III as rich CCVs in our study.
Results: Compared with wild-type group, ALDH2 deﬁciency signiﬁcantly reduced
perfusion recovery, small artery size and more muscle atrophy in the face of ischemia.
ALDH2-knockdown reduced hypoxia induced endothelial tubes formation in endo-
thelial cells in vitro. Further study indicated that mitochondrial ALDH2 regulated
angiogenesis through the classical hypoxia-inducible factor-1a (HIF-1a) / vascular
endothelial growth factor (VEGF) pathway, while toxic aldehydes and oxidative stress
might work as mediators. In our clinical study, logistic regression results indicated that
carrying ALDH2 mutant allele (genotype GA or AA) promote multi coronary stenosis
compared with wild type (genotype GG; P¼ 0.0025). In GG group the number of
ischemic coronary artery is positive relative to the good CCVs, while this response
was reversed in mutant group.
Conclusions: The current study demonstrated that ALDH2 has an intrinsic capacity to
regulate angiogenesis via HIF-1a and VEGF. ALDH2 mutant contributes to multi
coronary stenosis and decrease the ischemia induced development of coronary
collateral circulation. Therefore, it might be beneﬁcial for ALDH2*2 carriers to un-
dergo CTO lesions recanalization at early stage. Moreover, to increase ALDH2
expression and activity might be a novel strategy to enhance revascularization and
perfusion in chronic ischemia.er 16–19, 2014 j GW-ICC Abstracts/Basic and Translational Medicine
